Clinical Trial Update: COIN-B: COntrolled Interruption of Nucleos(t)Ide Analogue Treatment in Chronic Hepatitis B Infections [NA]

View source ↗

Summary

Update on the COIN-B trial evaluating controlled interruption of nucleoside analogue therapy in chronic hepatitis B; current status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Snippet

Sponsor: University Hospital, Antwerp | Conditions: Chronic Hepatitis B | NA | Status: UNKNOWN